IDNA vs. IBBQ
IDNA (iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund) and IBBQ (Invesco Nasdaq Biotechnology ETF) are both Health & Biotech Equities funds - IDNA tracks the NYSE FactSet Global Genomics and Immuno Biopharma Index while IBBQ tracks the NASDAQ / Biotechnology. Both are passively managed. Over the past 3 years, IDNA returned 6.48%/yr vs 11.95%/yr for IBBQ. Their correlation of 0.90 suggests significant overlap in exposure. IDNA charges 0.47%/yr vs 0.00%/yr for IBBQ.
Performance
IDNA vs. IBBQ - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, IDNA achieves a 9.51% return, which is significantly higher than IBBQ's 0.14% return.
IDNA
- 1D
- -2.18%
- 1M
- -2.18%
- YTD
- 9.51%
- 6M
- 10.53%
- 1Y
- 41.74%
- 3Y*
- 6.48%
- 5Y*
- -8.26%
- 10Y*
- —
IBBQ
- 1D
- -2.91%
- 1M
- -1.52%
- YTD
- 0.14%
- 6M
- 1.13%
- 1Y
- 38.35%
- 3Y*
- 11.95%
- 5Y*
- —
- 10Y*
- —
IDNA vs. IBBQ - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
IDNA iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund | 9.51% | 17.26% | -0.72% | -7.63% | -42.28% | -11.50% |
IBBQ Invesco Nasdaq Biotechnology ETF | 0.14% | 33.32% | -0.63% | 4.73% | -10.41% | -6.72% |
Correlation
The correlation between IDNA and IBBQ is 0.89, indicating a strong positive relationship between their price movements. Combining them offers limited diversification - they tend to fall together during downturns.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.89 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.89 |
Correlation (All Time) Calculated using the full available price history since Jun 14, 2021 | 0.90 |
The correlation between IDNA and IBBQ has been stable across timeframes, ranging from 0.89 to 0.90 - a consistent structural relationship.
IDNA vs. IBBQ - Sectors Allocation Comparison
Sectors
IDNA
IBBQ
Healthcare
Industrials
-
Basic Materials
-
-
Communication Services
-
-
Consumer Cyclical
-
-
Consumer Defensive
-
-
Energy
-
-
Financial Services
-
Real Estate
-
-
Technology
-
-
Utilities
-
-
Healthcare
IDNA
IBBQ
Industrials
IDNA
IBBQ
-
Basic Materials
IDNA
-
IBBQ
-
Communication Services
IDNA
-
IBBQ
-
Consumer Cyclical
IDNA
-
IBBQ
-
Consumer Defensive
IDNA
-
IBBQ
-
Energy
IDNA
-
IBBQ
-
Financial Services
IDNA
-
IBBQ
Real Estate
IDNA
-
IBBQ
-
Technology
IDNA
-
IBBQ
-
Utilities
IDNA
-
IBBQ
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
IDNA vs. IBBQ — Risk / Return Rank
IDNA
IBBQ
IDNA vs. IBBQ - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund (IDNA) and Invesco Nasdaq Biotechnology ETF (IBBQ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| IDNA | IBBQ | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 1.71 | 1.97 | -0.26 |
Sortino ratioReturn per unit of downside risk | 2.48 | 2.78 | -0.30 |
Omega ratioGain probability vs. loss probability | 1.28 | 1.33 | -0.05 |
Calmar ratioReturn relative to maximum drawdown | 4.09 | 4.89 | -0.79 |
Martin ratioReturn relative to average drawdown | 11.79 | 16.17 | -4.39 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| IDNA | IBBQ | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.71 | 1.97 | -0.26 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.29 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.10 | 0.14 | -0.04 |
Drawdowns
IDNA vs. IBBQ - Drawdown Comparison
The maximum IDNA drawdown since its inception was -68.26%, which is greater than IBBQ's maximum drawdown of -37.94%. Use the drawdown chart below to compare losses from any high point for IDNA and IBBQ.
Loading charts...
Drawdown Indicators
| IDNA | IBBQ | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -68.26% | -37.94% | -30.32% |
Max Drawdown (1Y)Largest decline over 1 year | -10.66% | -8.34% | -2.32% |
Max Drawdown (3Y)Largest decline over 3 years | -29.73% | -23.66% | -6.07% |
Max Drawdown (5Y)Largest decline over 5 years | -68.26% | — | — |
Current DrawdownCurrent decline from peak | -46.01% | -6.82% | -39.19% |
Average DrawdownAverage peak-to-trough decline | -36.24% | -16.83% | -19.41% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.70% | 2.52% | +1.18% |
Volatility
IDNA vs. IBBQ - Volatility Comparison
iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund (IDNA) has a higher volatility of 7.24% compared to Invesco Nasdaq Biotechnology ETF (IBBQ) at 6.88%. This indicates that IDNA's price experiences larger fluctuations and is considered to be riskier than IBBQ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| IDNA | IBBQ | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.24% | 6.88% | +0.36% |
Volatility (6M)Calculated over the trailing 6-month period | 18.21% | 15.21% | +3.00% |
Volatility (1Y)Calculated over the trailing 1-year period | 24.51% | 19.63% | +4.88% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 28.42% | 21.85% | +6.57% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 29.53% | 21.85% | +7.68% |
IDNA vs. IBBQ - Expense Ratio Comparison
IDNA has a 0.47% expense ratio, which is higher than IBBQ's 0.00% expense ratio.
Dividends
IDNA vs. IBBQ - Dividend Comparison
IDNA's dividend yield for the trailing twelve months is around 1.08%, more than IBBQ's 0.88% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
IBBQ Invesco Nasdaq Biotechnology ETF | 0.88% | 0.90% | 1.14% | 0.81% | 0.76% | 0.63% | 0.00% | 0.00% |
IDNA iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund | 1.08% | 1.18% | 0.98% | 1.04% | 0.54% | 0.70% | 0.26% | 0.80% |
Frequently Asked Questions
IDNA and IBBQ have a correlation of 0.89, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
IDNA has higher volatility (7.24%) compared to IBBQ (6.88%). In terms of maximum drawdown, IDNA dropped -68.26% vs IBBQ's -37.94%.
On 3-year performance, IBBQ leads with 11.95% vs 6.48% for IDNA. On fees, IBBQ is cheaper at 0.00% per year. On volatility, IBBQ has been the lower-risk option at 6.88%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 3-year period, IBBQ has performed better with a 11.95% return vs 6.48%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
IBBQ is cheaper with a 0.00% expense ratio, compared with 0.47% for IDNA.
IDNA has the higher dividend yield at 1.08%, compared with 0.88% for IBBQ.
IDNA tracks NYSE FactSet Global Genomics and Immuno Biopharma Index, while IBBQ tracks NASDAQ / Biotechnology. They also come from different issuers: iShares and Invesco. Their fees differ too: 0.47% for IDNA and 0.00% for IBBQ.
IBBQ currently has the higher Sharpe Ratio (1.97 vs 1.71), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for IDNA and IBBQ
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer